Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Sevko

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
BMC Urology|December 21, 2024
Immunomonitoring in bladder cancer: a short report on stability of leukocytes and proteins in refrigerated urine samplesAlexandra Sevko, Claudia Prevosto, Suvetha Ragavan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2009
Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organsSilvia Kimpfler, Alexandra Sevko, Sabine Ring, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 30, 2013
Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma modelAlexandra Sevko, Tillmann Michels, Melissa Vrohlings, et al.
The Journal of Investigative Dermatology|December 11, 2012
Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanomaAlexandra Sevko, Moshe Sade-Feldman, Julia Kanterman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma modelChristiane Meyer, Alexandra Sevko, Marcel Ramacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2015
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with IpilimumabChristoffer Gebhardt, Alexandra Sevko, Huanhuan Jiang, et al.
Oncoimmunology|September 22, 2017
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)Jessica C Hassel, Huanhuan Jiang, Carolin Bender, et al.
Oncoimmunology|July 9, 2015
Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironmentKirsten Ridder, Alexandra Sevko, Janina Heide, et al.
Molecular Cell|February 19, 2017
The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2Torsten Hartwig, Antonella Montinaro, Silvia von Karstedt, et al.
Oncotarget|July 2, 2014
Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signalsLaura Gatti, Alexandra Sevko, Michelandrea De Cesare, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
BMC Urology|December 21, 2024
Immunomonitoring in bladder cancer: a short report on stability of leukocytes and proteins in refrigerated urine samplesAlexandra Sevko, Claudia Prevosto, Suvetha Ragavan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2009
Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organsSilvia Kimpfler, Alexandra Sevko, Sabine Ring, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 30, 2013
Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma modelAlexandra Sevko, Tillmann Michels, Melissa Vrohlings, et al.
The Journal of Investigative Dermatology|December 11, 2012
Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanomaAlexandra Sevko, Moshe Sade-Feldman, Julia Kanterman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma modelChristiane Meyer, Alexandra Sevko, Marcel Ramacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2015
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with IpilimumabChristoffer Gebhardt, Alexandra Sevko, Huanhuan Jiang, et al.
Oncoimmunology|September 22, 2017
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)Jessica C Hassel, Huanhuan Jiang, Carolin Bender, et al.
Oncoimmunology|July 9, 2015
Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironmentKirsten Ridder, Alexandra Sevko, Janina Heide, et al.
Molecular Cell|February 19, 2017
The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2Torsten Hartwig, Antonella Montinaro, Silvia von Karstedt, et al.
Oncotarget|July 2, 2014
Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signalsLaura Gatti, Alexandra Sevko, Michelandrea De Cesare, et al.
Pageof 3